|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Mumps Virus IgG ELISA | Bevacizumab (Avastin®) ELISA | CMV IgM ELISA Assay | HE4 ELISA Assay | Lysozyme ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79882 | TM09010 | IB19206 | 404-10US | IB19131 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Mumps Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against Mumps Virus in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme linked immunosorbent assay (ELISA) for the determination of IgM antibody to Cytomegalovirus (CMV) in human serum. For research use only, not for use in diagnostic procedures. | The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer.... Read More | Solid phase direct sandwich ELISA for the determination of Lysozyme in human plasma, serum, or stool. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Tocilizumab (Actemra®) (mAb-based) | Bevacizumab (Avastin®) | DHT (Dihydrotestosterone) | Alpha2,6-Sialyltransferase (Alpha2,6-ST) | Human T-Cadherin(130K) |
| Sample Type | Serum and plasma. | Serum and plasma. | Human Serum | Serum, Blood Plasma, Cell Culture Supernatant | Human serum and EDTA-plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 0 / 6 to 200 ng/mL | Inquire | 15 to 900 pM | 0.1 to 40.0 ng/mL |
| Sensitivity | 2 ng/mL | 2 ng/mL | 6.0 pg/mL | 0.20 ng/mL | 0.01 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 1 hour, 45 min. total incubation time. | 50 mins (incubation) | 2 hrs 30 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |